Shares in Novo Nordisk ballooned by fifty three% past year amid increasing demand for its GLP-1 medication, initially applied to deal with diabetes, by people seeking to lose bodyweight. In January, it turned only the 2nd European firm in history, right after LVMH, to surpass a $five hundred billion valuation, in the procedure overtaking the luxuri